| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 7,330 | $30 | $190.5K |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 3,550 | $30 | $103K |
| J0897 | Injection, denosumab, 1 mg | 2,280 | $20 | $41K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 380 | $90 | $32.5K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 170 | $130 | $21.9K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 190 | $100 | $18.6K |
| 96415 | In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the… | 220 | $20 | $4.6K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 60 | $50 | $2.8K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 270 | $10 | $2.2K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 10 | $160 | $1.7K |